Evidence map›Paper›PMID 32816334›Full record

ArticleTransboundary and emerging diseases2021

Development of a bead-based assay for detection and differentiation of field strains and four vaccine strains of type 2 porcine reproductive and respiratory syndrome virus (PRRSV-2) in the USA.

Yin Wang, Wannarat Yim-Im, Elizabeth Porter, Nanyan Lu, Joe Anderson, Lance Noll, Ying Fang, Jianqiang Zhang, Jianfa Bai

Open access · greenAbstract read
In one paragraph

Article in Transboundary and emerging diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Yin WangKansas State Veterinary Diagnostic Laboratory, Kansas State University, Manhattan, KS, USA.
Wannarat Yim-ImDepartment of Veterinary Diagnostic and Production Animal Medicine, Iowa State University, Ames, IA, USA.
Elizabeth PorterKansas State Veterinary Diagnostic Laboratory, Kansas State University, Manhattan, KS, USA.
Nanyan LuKansas State Veterinary Diagnostic Laboratory, Kansas State University, Manhattan, KS, USA.
Joe AndersonKansas State Veterinary Diagnostic Laboratory, Kansas State University, Manhattan, KS, USA.
Lance NollKansas State Veterinary Diagnostic Laboratory, Kansas State University, Manhattan, KS, USA.
Ying FangDepartment of Diagnostic Medicine/Pathobiology, Kansas State University, Manhattan, KS, USA.
Jianqiang ZhangDepartment of Veterinary Diagnostic and Production Animal Medicine, Iowa State University, Ames, IA, USA.
Jianfa BaiKansas State Veterinary Diagnostic Laboratory, Kansas State University, Manhattan, KS, USA.ORCID https://orcid.org/0000-0002-0021-3036
Kansas State University · USIowa State University · US

Funding

Mentoring CoreP20GM103418 · NIGMS · UNIVERSITY OF KANSAS MEDICAL CENTER · PI Douglas E Wright · 2012 to 2026
$63.0M
National Pork Board 16-196NIGMS NIH HHS P20 GM103418
6 · The paper itself

Abstract

Porcine reproductive and respiratory syndrome (PRRS) remains one of the most economically devastating diseases in swine population in the United States of America. Due to high mutation rate of the PRRS virus (PRRSV) genome, it is difficult to develop an accurate diagnostic assay with high strain coverage. Differentiation of field strains from the four vaccines that have been used in the USA, namely Ingelvac PRRS MLV, Ingelvac ATP, Fostera PRRS and Prime Pac PRRS, adds an additional challenge. It is difficult to use current real-time PCR systems to detect and differentiate the field strains from the vaccine strains. Luminex xTAG technology allows us to detect more molecular targets in a single reaction with a cost similar to a single real-time PCR reaction. By analysing all available 678 type 2 PRRSV (PRRSV-2) complete genome sequences, including the 4 vaccine strains, two pairs of detection primers were designed targeting the conserved regions of ORF4-ORF7, with strain coverage of 98.8% (670/678) based on in silico analysis. The virus strains sharing ≥98% identity of the complete genomes with the vaccine strains were considered vaccine or vaccine-like strains. One pair of primers for each vaccine strain were designed targeting the nsp2 region. In silico analysis showed the assay matched 94.7% (54/57) of Ingelvac PRRS

Indexed as

AnimalsBase SequenceImmunomagnetic SeparationPorcine Reproductive and Respiratory SyndromePorcine respiratory and reproductive syndrome virusSus scrofaSwineUnited StatesVaccines, AttenuatedViral VaccinesVaccines, AttenuatedViral Vaccinesdetectiondifferentiationfield strainsLuminexPRRSVvaccine strains

Identifiers

PMID32816334
PMCPMC8895411
OpenAlexW3069045653

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.